End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
51.5 CNY | -1.25% | +1.72% | -13.30% |
04-26 | Jianzhijia Pharmaceutical Chain Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02-13 | JZJ Chain Drugstore Acquires 69 Pharmacies For 46 Million Yuan | MT |
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the last few months, analysts have been revising downwards their earnings forecast.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Drug Retailers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-13.30% | 919M | - | ||
-30.37% | 15.68B | B- | ||
-22.51% | 12.39B | B | ||
-22.88% | 6.74B | B | ||
-6.01% | 6.29B | C+ | ||
+11.76% | 6.26B | C | ||
+70.00% | 4.95B | C | ||
-1.90% | 4.7B | D- | ||
-5.58% | 4.03B | B | ||
-7.87% | 3.62B | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 605266 Stock
- Ratings Jianzhijia Pharmaceutical Chain Group Co., Ltd.